Tightly-bound ubiquinone in the Escherichia coli respiratory Complex I  by Verkhovsky, Michael et al.
Biochimica et Biophysica Acta 1817 (2012) 1550–1556
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbabioTightly-bound ubiquinone in the Escherichia coli respiratory Complex I
Michael Verkhovsky 1, Dmitry A. Bloch, Marina Verkhovskaya ⁎
Helsinki Bioenergetics Group, Institute of Biotechnology, PO Box 65 (Viikinkaari 1) FIN-00014 University of Helsinki, FinlandAbbreviations:BTP, 1,3-bis(tris(hydroxymethyl)methyla
β-D-maltopyranoside; DQ, decylubiquinone; Eh, ambient red
potential; HAR, hexaammineruthenium (III) chloride;
piperazineethanesulfonic acid; MOPS, 3-(N-morpholino)pr
hydrogen electrode; OTTLE, optically transparent, thin lay
TMH, transmembrane helix; UQ, ubiquinone; UQH
electrode; τ, time constant
⁎ Corresponding author. Tel.: +358 9 191 59749; fax
E-mail address: Marina.Verkhovskaya@Helsinki.Fi (M
1 Deceased, 4th October, 2011.
0005-2728/$ – see front matter © 2012 Elsevier B.V. Al
doi:10.1016/j.bbabio.2012.04.013a b s t r a c ta r t i c l e i n f oArticle history:
Received 6 March 2012
Received in revised form 23 April 2012
Accepted 25 April 2012
Available online 1 May 2012
Keywords:
Complex I
Ubiquinone
Binding site
Stopped-ﬂow
Redox titrationNADH:ubiquinone oxidoreductase (Complex I), the electron input enzyme in the respiratory chain of
mitochondria and many bacteria, couples electron transport to proton translocation across the membrane.
Complex I is a primary proton pump; although its proton translocation mechanism is yet to be known, it is
considered radically different from any other mechanism known for redox-driven proton pumps: no redox
centers have been found in its membrane domain where the proton translocation takes place. Here we
studied the properties and the catalytic role of the enzyme-bound ubiquinone in the solubilized, puriﬁed
Complex I from Escherichia coli. The ubiquinone content in the enzyme preparations was 1.3±0.1 per
bound FMN residue. Rapid mixing of Complex I with NADH, traced optically, demonstrated that both
reduction and re-oxidation kinetics of ubiquinone coincide with the respective kinetics of the majority of
Fe–S clusters, indicating kinetic competence of the detected ubiquinone. Optical spectroelectrochemical
redox titration of Complex I followed at 270–280 nm, where the redox changes of ubiquinone contribute,
did not reveal any transition within the redox potential range typical for the membrane pool, or loosely
bound ubiquinone (ca. +50–+100 mV vs. NHE, pH 6.8). The transition is likely to take place at much
lower potentials (Em ≤−200 mV). Such perturbed redox properties of ubiquinone indicate that it is tightly
bound to the enzyme's hydrophobic core. The possibility of two ubiquinone-binding sites in Complex I is
discussed.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
NADH:ubiquinone oxidoreductase (Complex I) couples the electron
transfer from NADH to ubiquinone (UQ) to proton translocation across
themembrane. Since no redox centers have been found in the enzyme's
membrane domain, the coupling mechanism is considered to be
radically distinct from the mechanisms known for other redox-driven
proton pumps. Complex I contains a low-afﬁnity UQ binding site
involved in the exchange of both UQ and ubiquinol (UQH2) with the
membrane pool. The loosely-bound UQ can be lost during the enzyme
isolation as it happens in other UQ-reducing cites e.g. in bacterial
photosynthetic reaction centers [1,2], cytochrome bc1 [3], and
cytochrome bd [4]. Mutagenesis [5–7] and recent structural studies
[8–11] proposed a plausible location for a UQ binding site at the
interface between the membrane and the hydrophilic domain of
Complex I. The site is located in a cleft of the hydrophilic domain facingmino)propane;DDM, n-dodecyl
ox potential; Em,midpoint redox
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l rights reserved.the membrane surface but at a signiﬁcant distance from it. Such a
location is quite unique for quinone-binding enzymes: in most of
them, quinone headgroup is bound within the membrane dielectric
with the quinone ring close to the surface (see e.g. [12,13]). In Complex
I, a chain of FeS clusters forms a wire providing rapid electron transport
from the FMNbound to the hydrophilic domain toUQ [14]. N2 is the last
cluster in the chain, adjacent to UQ, and situated in the hydrophilic
domain at a distance of 20–30 Å from the membrane surface [8,11].
Efﬁcient electron transfer between N2 and UQ can only be achieved if
the distance between them does not exceed 14–15 Å. To ensure such
a distance, the UQ ring should move out from the membrane domain
at ~10 Å, leaving at least one of the hydrophobic isoprenoid tail
segments exposed to the rather hydrophilic protein milieu between
the membrane and hydrophilic domains. If one considered the
movement of the same UQ molecule between a membrane-exposed,
“exchangeable” site and an N2-proximal, “electron-transfer” site,
binding of the hydrophobic tail would present an energetic problem.
Brandt and co-authors [5–7] suggested that a local hydrophobic zone
in the interface region facilitates binding of the tail at the N2-proximal
site. Although the structure of the hydrophilic and hydrophobic
domains of Complex I has been resolved at resolutions of 3.1 and
3.0 Å, respectively [9,15], the structure of the interface region formed
by the loops of both membrane, Nuo A, H, J, and K, (Nqo 7, 8, 10 and
11) and hydrophilic, Nuo B, and CD (Nqo 4, 5 and 6) subunits remains
unclear [11]. However, such hydrophobic segments ﬁlling the interface
cannot be predicted from the primary amino acid sequences.
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between the N2-proximal and exchangeable sites could be overcome
if Complex I contained two, rather than one, UQ molecules within the
electron-transfer distance between them: one tightly bound at the
N2-proximal site and never leaving it, and the other readily
exchangeable with the membrane quinone pool. In this case the tail
of the exchangeable UQ will always remain in the hydrophobic
membrane surrounding. The existence of two UQ-binding sites has been
proposed by Ohnishi and co-authors [16–19] based on their EPR study
of Complex I in the natural membrane fragments, submitochondrial
vesicles. Under turnover, Complex I showed two semiquinone EPR signals
originating from two different semiquinone species with different spin-
relaxation behavior (Qfast and Qslow) and distances from N2; only one of
which being sensitive to transmembrane electric potential. This allowed
the authors to conclude that the signals come from UQ located in two
different binding sites in Complex I. However, since these signals were
not quantiﬁed, and the possibility still remains that the two signals
originate from two different states of the same UQ molecule, rather
than from two different molecules.
The presence of an equimolar amount of UQ in detergent-solubilized,
puriﬁed Complex I can itself indicate its tight binding. In the literature,
the ratio between the UQ and FMN content (UQ:FMN) in isolated,
puriﬁed Complex I varies between the substoichiometric value of 0.2–
0.4 [20] and 1.0 [21]. Previously, we also found one molecule of UQ per
protein in the puriﬁed Complex I from Escherichia coli [22]. Here we
have further studied the physical–chemical properties of this enzyme-
bound UQ, and elucidated its role in enzyme turnover.2. Materials and methods
2.1. Bacterial growth and puriﬁcation of Complex I
The E. coliMWC215 (SmR ndh::CmR) strainwas grown in LBmedium
at 37 °C in a 25 L fermentor and harvested at the late exponential growth
phase. The membranes for Complex I puriﬁcation were prepared by
passing the cells through the APV Gaulin homogenizer, as described in
[23]. Complex I was puriﬁed by the two consecutive chromatography
steps using anion exchanger DEAE-Trisacryl M (Bio-Sepra) columns
and gel ﬁltration on Superdex 200 prep grade (GE Healthcare),
respectively [24].2.2. Measurements of catalytic activity
Hexaammineruthenium (HAR) and decylubiquinone (DQ) reductase
activities of membrane-bound or puriﬁed Complex I were measured by
following NADH oxidation at 340 nm (ε=6.2 mM−1cm−1) in Buffer A
containing 25 mM HEPES-BTP, pH 7.5, and 3 mM KCl at +30 °C.
Substrates (100 μM DQ, 360 μM HAR and 200 μM NADH) were added,
as indicated. For the measurements of the ubiquinone reductase activity
of puriﬁed, solubilized Complex I, Buffer A was supplemented with
0.005% DDM and 20 nM ubiquinol oxidase bo3.2.3. Analytical procedures
Protein concentration was determined in the membrane-bound and
the puriﬁed enzyme by the BCA protein assay reagent kit and Pierce
660 nmprotein assay reagent, respectively (both fromThermoScientiﬁc).
Bovine serum albumin was used as a standard in both cases. FMN was
extracted by acid [25] and its content was determined ﬂuorimetrically
on a Hitachi F-7000 spectroﬂuorimeter. UQwas extracted withmethanol
and cyclohexane as described [21] and its content was determined by the
difference UV spectra between borohydride-reduced and air-oxidized
states (ε272=12.3 mM−1 cm−1).2.4. Stopped-ﬂow experiments
Complex I (3 μM) in Buffer A (200 mM MOPS/KOH, pH 6.75) was
rapidly mixed (dead time 3 ms) with an equal volume of Buffer a
containing 8 μM NADH. Rapid mixing experiments were carried out
using a stopped-ﬂow spectrophotometer equipped with a diode array
detector capable of recording spectra at a rate up to one permillisecond
(Unisoku Instruments). All the experiments were conducted at room
temperature.
2.5. UV–vis spectroelectrochemical redox titration
UV–vis spectroelectrochemical redox titration of Complex I was
performed at 21 °C using the OTTLE cell (0.3 mm optical path length)
as described in [26] with minor modiﬁcations. The working electrode
(WE) potentials within the range from −450 mV to +100 mV vs.
NHE were applied using a PAR263A potentiostat (Princeton Applied
Research). Absolute optical absorption spectra were recorded in the
spectral range of 240–650 nm using a Cary 300 spectrophotometer. At
each potential step, the onset of equilibrium on WE was determined as
the point where changes in the cell current were no longer signiﬁcant.
To accelerate the redox equilibrium between WE and the enzyme, the
following redox mediators were added: hexaammineruthenium (Em=
+50 mV), 200 μM; pentaaminechlororuthenium (Em=−130 mV),
200 μM; cobalt (III) sepulchrate (Em=−350 mV), 200 μM. No
optical contribution from hexaammineruthenium was detected in
the studied spectral range. Small contribution of cobalt sepulchrate
and pentaaminechlororuthenium was registered and subtracted
from the data. Both oxidative and reductive titrations were
performed without signiﬁcant hysteresis. For the redox titrations,
45 μl of Complex I (40 mg/ml), solubilized in Buffer B, containing
100 mM MOPS/KOH (pH 6.75), 100 mM KCl, and mediators was
degassed and saturated with 99.99% Ar gas (AGA) using a locally-
built vacuum/gas line and anaerobically loaded into the OTTLE cell.
The cell was also washed with anaerobic Buffer B before loading
with the sample. Since the concentrated enzyme stocks before
dilution contained large amount of detergent (DDM), it was not
necessary to add it to Buffer B.
2.6. Data analysis
Data analysis was carried out using the MATLAB software (the
Mathworks, Inc.). Decomposition of the kinetic data surfaces was
achieved by global ﬁtting run under a MATLAB interface using the
Rakowsky algorithm as described (Eq. 9 and Supporting Material:
http://www.biophysj.org/biophysj/supplemental/S0006-3495(09)00
696-1 in [27]).
3. Results
3.1. Properties of puriﬁed Complex I
The enzyme activitymeasured as the rate of NADHoxidation upon the
reduction of an artiﬁcial donor (HAR) and the quinone reductase activity
measured as the rate of NADH oxidation upon reduction of DQ were
120–140 and 20–25 μmol min−1 mg−1, respectively. Quantiﬁcation of
FMN and quinone in the Complex I preparations provided a UQ:FMN
(mol/mol) ratio slightly higher than unity (1.3±0.1).
3.2. Kinetics of the reduction and re-oxidation of Complex I
A stopped-ﬂow setup was used to study the rapid kinetics of the
reduction initiated by NADH and subsequent re-oxidation of Complex
I. The enzyme (~3 μM) was mixed with NADH (8 μM) at a 1:1 volume
ratio. Such a low NADH concentration was used for two reasons:
(i) The dead time of the stopped-ﬂow setup was 3 ms, while the
Fig. 2. Spectral components obtained by global ﬁtting of the experimental kinetic data.
(A) The fastest component (τ1=8.3 ms) representing the very beginning of the reaction.
(B) The τ2=2.1 s component showing mostly the NADH consumption. (C) The slowest
component (τ3=5.7 s) representing re-oxidation of the enzyme. (D) The ﬁnal spectrum
(the sum of all spectral changes during the reaction) comprising mostly the consumed
NADH, but also showing a contribution of the unknown 255 nm band. Zero time spectrum
(dashed line in panel D) represents the spectral changes takingplace in thedead-time of the
setup; it is similar to the fastest component (panel A). Data are taken from Fig. 1.
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below the apparent Km (7.2 μM, [14]) to slow down the reaction for
better time resolution; (ii) The optical spectra of NADH and Complex I
overlap in the UV region, so that the absorbance of NADH at high
concentration made the kinetic analysis impossible. In control
experiments, we mixed the same solution of NADH with the buffer
and obtained an initial NADH spectrum, which was used for the data
treatment. Separately, we obtained the spectrum of 8 μM NAD mixed
with the buffer. The difference spectrumNADH−NAD+was subtracted
from the data surface. As a background we took the spectrum obtained
by the mixing of 3 μM oxidized Complex I with the buffer in a 1:1 ratio.
The experimental spectra, taken every millisecond after mixing, are
presented in Fig. 1A. The red curve (peak at 340 nm) shows the
spectrum of NADH added at zero time. The broad negative peak
(minimum at 450 nm) corresponds to the redox changes of FMN and
the FeS clusters. The arrow indicates the position of the UQ band
(275 nm). The reaction was followed for 50 s. The kinetic curves at
255, 450 and 275 nm are shown in Fig. 1B. Since the UV spectral band
for the UQ redox difference spectrum overlaps with the band at
255 nm where spectral redox changes are opposite, the redox changes
of UQ during the reaction were measured as the difference:
AUQ
app ¼ A275– A255 þ A297ð Þ=2 ð1Þ
It is clear from the data that the reduction of Complex I occurred
mostly in the dead time. Only the tail of this reaction can be observed
within the ﬁrst 70–100 ms. The redox state of the enzyme stayed
almost unchanged between 100 and 1000 ms and then re-oxidation
proceeded. Global ﬁtting of the kinetic data surface yielded three
spectral components (Fig. 2). The ﬁrst component with a time
constant τ1 of 8.3 ms (Fig. 2A) represents the reduction of Complex
I. The negative absorbance in the visible area with a broad minimum
at 420–460 nm derives mainly from the FeS clusters. The trough at
330–340 nm shows NADH oxidation. There could be also some
contribution from the reduction of the FeS cluster(s), since the band
at 300–360 nmwas found in the redox spectra of some of FeS clusters
[28]. The positive peak at 255 nm is of unknown origin. The UQ band
looks as a shoulder at 273–278 nm between positive and negative
peaks. The second component with τ2=2.1 s (Fig. 2B) presents a
clear spectrum of the redox-active band of NADH with a trough at
340 nm. During this time the redox state of the enzyme does not
change and only NADH is consumed. The third, slowest component
with τ3=5.7 s (Fig. 2C) is practically a mirror reﬂection of the ﬁrstFig. 1. Reaction of Complex I with NADH. (A) A set of spectra taken every 1 ms after
mixing Complex I with NADH. The red curve is the spectrum of the redox-active band of
4 μM NADH present in the solution after mixing at zero time. (B) The kinetic transients
after mixing, taken at 450 nm (FMN and FeS, blue line) and 255 nm (an unknown
compound, green line) and at the 275 nm band (ΔA275−(ΔA255+ΔA297)/2, FMN and
UQ, red line). The kinetics shows that the main reduction events happen during the
dead time of the setup, followed by a quazi-equiliblium state and then by re-oxidation.
In (A), arrow shows the position of the UQ redox difference absorption band. For
conditions, see: Materials and methods.fastest component and shows the slow re-oxidation of Complex I
after exhaustion of NADH. Fig. 2D shows ﬁnal and zero time spectra
obtained by a global ﬁt. The ﬁnal spectrum is the sum of all redox
changes during the measurements; since the enzyme was reduced
and re-oxidated this spectrum derives from NADH oxidation and
mainly shows the amount of consumed NADH, although small
residual changes at 250–260 nm remain. The zero time spectrum
presents the redox events that happen during the dead time. The
zero time spectrum is very similar to the ﬁrst fast components
indicating that they reﬂect the same process of Complex I reduction
and NADH oxidation. Fig. 3 shows the sum of these two spectra: it
represents the events that happen during ~15 ms after mixing, from
which 0.6 of the ﬁnal spectra (NADH oxidized during dead time and
the fast phase) is subtracted. The obtained spectrum of rapidly
reduced Complex I consists of the well known redox spectrum of
Complex I in the UV–vis region with the major contribution of FeS
clusters and possibly FMN (see below), a negative band at 330 nm,
also most probably due to FeS clusters, a positive peak at 255 nm of
unknown origin, and a trough at 276–278 nm which can be either
due to reduction of FMN or UQ, or both. Both UQ and FMN haveFig. 3. Fast redox changes in Complex I. The sum of zero time spectrum and the fastest
components corrected for the redox active NADH band (solid line) presents the redox
events that happen in approximately 15 ms upon reduction of Complex I (1.5 μM) . For
comparison, the redox difference spectra of 1 μM ubiquinone-1 (Q1, dashed line) and
1 μM FMN (dotted line) are shown. Conditions: as for Fig. 1.
Fig. 5. Effect of rolliniastatin on optical changes of Complex I after mixing with NADH.
Kinetic curves with (dotted lines) and without (solid lines) 3 μM rolliniastatin
(concentration after mixing) were taken at selected wavelengths characteristic for
FMN and FeS centers (450 nm), FMN and UQ (see: Eq. (1)), and an unknown band
(255 nm). Conditions, as for Fig. 1.
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contribute to the 275 nm trough. However, Complex I was not fully
reduced upon the reaction; only 2.4 μM NADH was oxidized during
the ﬁrst 15 ms after mixing. This amount is not enough to reduce all
redox centers of 1.5 μM Complex I, which can hypothetically accept
11 or 12 electrons per molecule (1 FMN, 8 FeS clusters and 1 UQ).
FMN has the lowest midpoint redox potential among all redox centers
of Complex I (−350 mV); therefore, it seems highly improbable that
it signiﬁcantly contributes to the redox spectrum of the fast events.
Indeed, comparison of this spectrum with the redox titration data
obtained in our group previously also indicates that Complex I was
less than 50% reduced during the fast events and that FMN was in
the oxidized state (Fig. 4, see also [26]).
The stopped-ﬂow experiment was also performed at the same
conditions but in the presence of 6 μM rolliniastatin, a speciﬁc
inhibitor of Complex I, which was added to Complex I before mixing
with NADH (ﬁnal rolliniastatin concentration after mixing was
3 μM). We note that neither amplitude nor kinetics of the rise phase
at 275 nm (Eq. (1)) is affected by the inhibitor. This result may
indicate that (a) the 275 nm kinetics does not reﬂect the UQ
reduction, which is unlikely; (b) the 275 nm kinetics shows the UQ
reduction and the latter is not affected by the inhibitor (Fig. 5). Re-
oxidation of FeS clusters was slightly slower in the presence of
rolliniastatin and the most prominent effect of the inhibitor was a
decrease of the rates of both reduction and re-oxidation of the
unassigned band at 255 nm (Fig. 1B). Under the experimental
conditions, the oxidation phase is slow because it is limited by the
lack of added electron acceptor; the autooxidation of Complex I by
oxygen is a relatively slow process, which does not necessarily
directly involve UQ. In separate experiments we observed that at
these concentrations of protein and rolliniastatin the ubiquinone
reductase activity of Complex I was inhibited by ~90% which is in
accordance with the data reported by us previously [25]. Altogether
these data indicate that the inhibitor does not block the electron
transport between FeS cluster N2 and the presumed, tightly-bound
UQ, but does block it between the latter and the loosely-bound UQ
(or block the release of tightly-bound ubiquinone if properties of
quinone-binding site could be altered upon turnover (see below)).
3.3. UV–vis spectroelectrochemical redox titration
Puriﬁed Complex I was electrochemically reduced or oxidized in the
OTTLE cell. In this study, the optical redox changes were followed not
only in the visible region as before [26] but also in theUV. The data surface
is presented in Fig. 6A. The n=2 redox change of UQ (UQH2−UQ) is
expected to be seen in the spectral region of 270–280 nm. The analysis
of redox behavior of the UQ 270–280 nm band is complicated due to
(i) potential contribution of n=2 redox changes of FMN in the sameFig. 4. Partial reduction of Complex I upon fast events after mixing with NADH.
Spectrum of the fast events (dotted line), taken from Fig. 3. Redox spectra of Complex
I at selected redox potentials, as indicated (solid lines). The spectroelectrochemical
data in visible region are taken from [26].region (Fig. 3); and (ii) overlappingwith the redox spectrum of unknown
origin that changes in the opposite direction (Figs. 1A, 6A). However,
when the absorption points were calculated by the “triangle approach”
(Eq. (1)), the titration proﬁle indicates a transition with a midpoint
redox potential (Em) of−200–−180 mV (Fig. 6B). The spectrum of this
transition cannot be decomposeddue to its complexity. Three FeS clusters
with known Em of −200 (N2) and −235 mV (N1a and N6b) (n=1
transitions) but unknown optical spectrum shape and extinction
coefﬁcients contribute to the spectrum [26]. A possible contribution of
FMN at 270–280 can be checked by its prominent band at 450 nm.
Although the titration curve at 450 nmwhere both FMN and FeS clusters
contribute, cannot be decomposed due to overlapping absorption from
several redox centers, it shows that the majority of these centers have
midpoint redox potentials lower than−270 mV (Fig. 6B) in accordance
to our data on optical and EPR redox titrations [26]. We did not ﬁnd a
clear two-electron transition at 450 nm at redox potentials around
−200 mV that would have been attributed to FMN (in fact, the latter
revealed the n=2 transition at ~−350 mV) [26,29]. This makes the
contribution of FMN to the observed redox changes at 270–280 nm
band unlikely. Spectra of DQ (1 μM) and FMN (1 μM) shown in Fig. 3
are close to those expected in Complex I (1.5 μM). Since we do notFig. 6. UV–vis spectroelectrochemical redox titration of Complex I. (A) Spectra taken at
a range of redox potentials upon redox titration (Eh −430÷+100 mV). (B). Titration
curve at 275 nm (data points calculated with a “triangle approach” (Eq. (1)), red
circles) reﬂecting redox transitions of FMN and UQ, and theoretical n=2 curve (red
line, Em=−200 mV); titration curve at 450 nm (blue circles) reﬂecting redox
transitions of FMN and the majority of FeS clusters; titration curve at 250 nm (black
circles) reﬂecting redox transitions of an unidentiﬁed band. In (B), the results of 3
independent titration data sets are combined.
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250 nm, with which the ubiquinone band interferes, we cannot estimate
the real size of the UQ band in the UV range. Certainly the transition at
275 nm tracked as A275app=A275−(A255+A297)/2 (Eq. (1)) reﬂects only a
fraction of the full spectral changes of UQ in the UV range, so that its full
extent should be consistent with the expected, concentration-based
value.
The contributionof the n=1transition ofUQ (for example, UQ/UQ•−)
to the observed UV optical spectral changes is also unlikely: in the cryo-
EPR redox titration of Complex I no radical species was observed at the
potentials at least as low as−350 mV [26,29].
UQ and a fraction of FMN released from the enzyme (the latter with
a higher Em~−220 mV) could both be responsible for the optical
changes at 270–280 nm. However, the most important result is that
no redox changes of the UQ band were observed at relatively high
ambient redox potentials (+100÷−100 mV), where the Em of a
loosely bound, exchangeable UQ is expected. (Note that the Em,7 of
pool UQ is +80 mV). On the other hand, all observed redox transitions
in the UQband occur atmuch lower redox potentials with themidpoint
at approximately−200 mV.
4. Discussion
Under aerobic condition E. coli cells contain less than 10% of
menaquinone in comparison to ubiquinone [30]. By unknown reason
Complex I from aerobically grown E. coli cells is incapable to reduce
menaquinone. Since we were using the bacterial cells grown at high
aeration for Complex I isolation we did not consider any effect of
menaquinone. The literature data vary on the amount of enzyme-
bound UQ in different Complex I preparations; the UQ:FMN ratio
was found to be 0.2–0.4 (yeast mitochondria, [20]) and 1 (bovine
mitochondria, [21]). We found 1.3±0.1 UQ molecules per FMN in
our puriﬁed Complex I preparations from E. coli. In this study we
investigated the kinetic and thermodynamic properties of this UQ.
We found that its reduction and re-oxidation correlates kinetically
with the majority of the FeS clusters. This ﬁnding proves that the
presence of UQ in the preparation is not a result of unspeciﬁc binding
or contamination due to hydrophobicity of the enzyme and retained
lipids; on the contrary, the bound UQ, indeed, directly participates
in the Complex I turnover.
Binding of a UQ species to a binding site in the enzyme leads to a
shift in its apparent midpoint redox potential with respect to the
potential of the unbound (free) quinone in the membrane pool:
Eboundm ≈E
pool
m −30 lg
KUQH2D
KUQD
ð2Þ
where Embound and Empool are the midpoint redox potentials for the
2-electron reduction/oxidation of the enzyme-bound and free UQ,
respectively; KDUQH2 and KDUQ are the dissociation constants for the
enzyme-UQH2 and enzyme-UQ complexes, respectively. The ratio
K ¼ K
UQH2
D
KUQD
indicates the directionality of the enzyme's catalytic activity:
when κ≫1, the enzyme preferentially binds the oxidized UQ, which
is optimal for a UQ reductase reaction; when κ≪1, the enzyme
preferentially binds UQH2, which is optimal for UQH2 oxidation. It has
been shown that the bacterial Complex I is a nearly reversible enzyme
with respect to UQ/UQH2 (see e.g. [31]); a similar situation was
extensively studied with a loosely-bound quinone in e.g. bacterial
reaction centers and many other weak binding sites, where κ is
close to unity (see e.g. [32]). A typical value for the redox midpoint
potential of UQ freely dissolved in the lipid bilayer membrane or
bound to the detergent micelles when the membrane enzyme
is isolated (ubiquinone pool) has been established for different
membrane systems and falls within the range +60÷+100 mV vs.
NHE (pH 7, e.g. [32–35]). Noteworthy, in the redox titrationexperiments, we failed to observe any such transition in the UQ
absorption band at 275 nm (Eq. (1)). On the other hand, in many
cases a tightly bound UQ has the n=2 redox transition at much
lower potentials (see e.g. [36,37]) indicating preferential binding of
the oxidized form. Such preference for the oxidized form is natural
when the bound UQ species acts not as a terminal electron and proton
acceptor but rather as an electron transport element, even if the proton
charge compensation can occur within the time frame of UQ reduction/
re-oxidation. In the present study the apparent midpoint potential of
the observed transition at 275 nm characteristic for the UQ/UQH2
transition (Eq. (1)) was found to be lower than −200 mV, although
its exact value could not be determined. Such a low value indeed
indicates a tight and speciﬁcally bound species.
Noteworthy, for a tightly-bound UQ species there is another factor
lowering its Em rather than just preferential binding of the oxidized
form: the protein surrounding can hamper the access of protons to
UQ so that its reduction is not accompanied by protonation. In this
case semiquinone anion, UQ•− (n=1), and deprotonated quinol
species, UQH− or even UQ= (n=2), can be formed at rather low
redox potentials, the way it occurs in the aprotic solvents (see e.g.
[38,39] and references therein). Protonation is indeed not required
for a tightly-bound UQ to serve as an electron transfer element. Note
however, that the lack of protonation of the UQ reduced species
(i) usually requires hydrophobic protein surrounding and (ii) can only
be observed transiently on short time scales (see e.g. [32,36,37]). The
hydrophilic nature of the putative location of the UQ binding site in
Complex I and the equilibrium conditions of the redox titration
experiments make the formation of unprotonated, reduced UQ species
unlikely, since the enzyme should also bind a high redox-potential UQ
exchangeable with the quinone pool, there can be two explanations of
the results.
(a) There is one quinone-binding site, within which UQ can occupy
two positions: tightly bound and exchangeable. UQ in the “as
prepared” Complex I is “frozen” in the tightly-bound state
characterized by a low redox potential. The arrival of the ﬁrst
electron(s) should release it (e.g. by protonation) and displace
to the high redox-potential, exchangeable, position. This
situation can either (i) be applicable to Complex I turnover
when the ubiquinone movement initiates the conformational
changes that result in protons translocation or (ii) it can be a
peculiarity of the resting-state enzyme and concern only the
ﬁrst turnover.
(b) Complex I contains two quinone binding sites. Since no other
redox centers except FMN, FeS clusters and UQ are found in
Complex I it is evident that UQ should be located within
the electron tunneling distance from N2 cluster providing
reasonable electron transfer rate (b15 Å, edge-to-edge distance).
The ﬁrst estimation of the latter distance was performed by EPR
studies based on the spin–spin interactions between N2 and
ubisemiquinone in Complex I in closed membrane vesicles from
bovine mitochondria [17,40]. The values of 8–11 Å was obtained
from the EPR signal splitting data for N2 [17] and 10–13 Å, from
the power saturation proﬁles of semiquinone species [40]. With
another approach, extensive studies of the mitochondrial
Complex I inhibitor resistance caused by point mutations in the
49 kDa and PSST subunits (see [7] for a review) led the authors
to conclude that the UQ binding site is located close to the
interface between these two subunits and the residue responsible
for binding interaction is a conserved tyrosine (Y144 in 49 kDa,
Yarrowia lipolytica enzyme) in the immediate proximity to the
N2 cluster [7]; therefore, the distance between N2 and the
quinone ring is ~10 Å [41]. All these results are in a good
agreement; however, since the location of N2 is known, they
indicate a very unusual position of UQ in the hydrophilic part of
the enzyme, far away from the membrane dielectric.
1555M. Verkhovsky et al. / Biochimica et Biophysica Acta 1817 (2012) 1550–1556Replacement of close to N2 (6–8 Å) Tyr144 which abolish
Complex I activity with some quinones but retains with another
[42] argues to exchangeable quinone in the vicinity of N2.
However, similar effect was observed when a number of residues
in 49 kDa and PSSTwere substituted [43]; these residues reside at
the distance of 11–19 Å fromN2, they are closer to themembrane
and cover a signiﬁcant area judging the resolved structure of
hydrophilic domain of Thermus thermophilus (PDB ID: 3M9S) up
to 20–22 Å between some of them, (Met88 (Met 127 in PSST):
Phe150 (Phe207 in 49 kDa) 24 Å) what could indicate the
importance of the whole structure in this area for ubiquinone
reduction and does not contradict second quinone binding site.
Recent data onphotoafﬁnity labeling of Complex I by azidoquinazoline
showed that this compound binds at two subunits of mitochondrial
Complex I, namely 49 kDa (NuoCD in E. coli) and ND1 (NuoH in E.
coli) [44,45]. Quinazolines, strong inhibitors of Complex I and
structurally similar to UQ, presumably occupy the quinone binding
site(s). The N-terminus of subunit 49 kDa (Asp41-Arg63) and the loop
between the 5th and 6th TMH in subunit ND1 have been determined as
the location of the bound azidoquinazoline [44]; however, it does not
allow to determinewhether these two subunits form a common quinone
binding site or there are two separate sites. Unfortunately, in the crystal
structure of the entire T. thermophilus Complex I (PDB ID: 3M9S) the
area between hydrophilic and hydrophobic domains, which should be
ﬁlled with Nqo8 (NuoH in E. coli) and small membrane subunits loops is
not resolved [11]. However, the location of the binding site on subunit
Nqo4 (NuoCD in E. coli) can be estimated using the 3M9S structure
coordinates. The residues Asp41 and Arg63 (49 kDa subunit) ﬂanking
the quinone binding site region in bovine mitochondrial Complex I
correspond to Asp20 and Arg42, respectively, in subunit Nqo4 in
the T. thermophilus enzyme. Fig. 7 shows the resolved residues,
Met26-Gly31 and Gly39-Arg42 in T. thermophilus, correspondent to theFig. 7. Hypothetical UQ-binding sites in Complex I. Shown by numbers, are the
estimated distances between the FeS cluster N2 and the most proximal (Leu41 and
Gly39) and the most distal (Met26) residues, respectively, resolved in the subunit
Nqo4, located within the limits of the quinazoline-binding site [44]. The corresponding
distances in Å are indicated. Subunits Nqo4 (ochre), Nqo6 (gray), and Nqo9 (tan), are
shown. White dotted line indicates the approximate position of the membrane surface.
Below the line, the TMH from the membrane subunits Nqo8, Nqo7, Nqo10, and Nqo11,
are partially shown in green. Two probable ubiquinone headgroup binding sites are
indicated by the red circles. Amino acid residues important for the UQ binding are
also shown as licorice (see: Discussion). The ﬁgure is produced using the X-ray
coordinates for the entire Complex I from Thermus thermophilus (PDB ID: 3M9S).Asp41–Arg63 region in the bovine enzyme. The residues closest to N2
(Gly39 and Leu41) are located 14–15 Å away from N2; the most remote
residue (Met26) is ~36 Å away from N2, much closer to the membrane
surface and probably forms a contact with the 3rd loop of subunit Nqo8.
Therefore, there is a possibility of two binding sites as shown in Fig. 7:
one, in the vicinity of N2 and the other, for loose binding in the interface
of hydrophilic and hydrophobic domains and how it was found in other
enzymes. Loosely bound, exchangeable UQ can be easily washed out
upon Complex I puriﬁcation that includes intensive enzyme treatment
with detergent, hence we observe only tightly bound ubiquinone with
oddly low midpoint potential indicating its very speciﬁc coordination
in the protein. Such rendering of the two quinone binding sites can
explain the efﬁcient electron transfer from N2 (and thus, from NADH)
to the membrane-exchangeable UQ without having to propose (see:
[8]) the energetically unfavorable movement of the UQ isoprenoid
chain between the membrane and hydrophilic domains of Complex I.
However, the probability that there could be two states of a single
ubiquinone-binding site, for tight and loose binding, and observed
ubiquinone behavior is a result that “as prepared” enzyme is “frozen”
in one particular mode cannot be yet ruled out.Acknowledgements
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